CIO Placed for Global Health Investment Corporation by Occam
In January 2025, Occam recruited Vidya Vasu-Devan as Chief Investment Officer of Global Health Investment Corporation (GHIC), a leading New York-based impact fund focused on global health innovation for more than a decade. Limited Partners include The German government and BARDA.
Vidya previously served as Chief Strategy Officer of a venture-backed newco focused on vaccine development after spending over a decade in leadership investment roles at the Bill & Melinda Gates Foundation. There, she most recently served as Director of the Foundation's Strategic Investment Fund.
Vidya began her career in healthcare and financial services investment banking with Goldman Sachs. She holds a B.A. in Astrophysics from Columbia University and an M.B.A. from Stanford University.
Occam Global is a biotech executive search, recruiting, and leadership advisory firm with specialties across technological fields, including Biotech, TechBio, AI-ML, Cell/Gene Therapy, Diagnostics/Genomics, Medical Devices, Research Tools, Digital Health, Alternative Energy, AgTech, EdTech, Robotics as well as adjacencies within Venture Capital and Private Equity. Occam helps build biotech executive leadership teams that meet the demands of the rapidly developing, competitive, and challenging industries it serves. Occam Global recruits leading C-Suite executives and board members for the most exciting and innovative clients across the world with a specific focus on the UK, Continental Europe, the US, and Asia.